Ecofibre Ltd (ASX: EOF) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Ecofibre Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Ecofibre Ltd (ASX: EOF)
Latest News
Share Fallers
Why AMP, Ecofibre, Magellan, & Vita shares are sinking today
Share Market News
Up in smoke! Why ASX cannabis shares are having a bleary day
Share Market News
Why the Ecofibre (ASX:EOF) share price is rising today
Best Shares
5 top ASX cannabis shares in 2020
Healthcare Shares
How did ASX cannabis shares perform last quarter?
Share Market News
Ecofibre (ASX:EOF) share price plummets 24%. Here's why
Share Market News
3 ASX growth shares that could help you retire rich
Share Market News
Ecofibre share price on watch after doubling profits
Share Market News
Ecofibre share price flat on acquisition news
Share Market News
ASX cannabis shares adjust to coronavirus environment
Share Gainers
Why Afterpay, Ecofibre, Mesoblast, & Zip Co shares are racing higher
Share Market News
Stock of the day: Ecofibre share price jumps on profit guidance
EOF ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Ecofibre Ltd
Ecofibre Ltd through its subsidiaries is engaged in three business lines including Ananda Health, Ananda Food and Hemp Black. Amanda Health includes Production and sale of hemp related nutraceutical products focused on the US. Ananda Food includes Production and sale of hemp related food products in Australia. Hemp Black includes the development of hemp related fibre products globally.
EOF Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
27 Mar 2024 | $0.10 | $0.00 | 0.00% | 6,438 | $0.10 | $0.10 | $0.10 |
26 Mar 2024 | $0.10 | $-0.01 | -10.00% | 5,910 | $0.10 | $0.10 | $0.10 |
25 Mar 2024 | $0.10 | $0.01 | 11.11% | 172,553 | $0.10 | $0.11 | $0.10 |
22 Mar 2024 | $0.09 | $-0.01 | -10.10% | 34,491 | $0.10 | $0.10 | $0.09 |
21 Mar 2024 | $0.10 | $0.00 | 0.00% | 5,070 | $0.10 | $0.10 | $0.10 |
20 Mar 2024 | $0.10 | $0.01 | 10.99% | 9,667 | $0.10 | $0.10 | $0.10 |
19 Mar 2024 | $0.09 | $0.00 | 0.00% | 125,215 | $0.09 | $0.09 | $0.09 |
18 Mar 2024 | $0.09 | $0.01 | 11.76% | 95,366 | $0.09 | $0.09 | $0.09 |
15 Mar 2024 | $0.09 | $0.01 | 12.50% | 18,903 | $0.08 | $0.09 | $0.08 |
14 Mar 2024 | $0.08 | $0.00 | 0.00% | 53,056 | $0.08 | $0.08 | $0.08 |
13 Mar 2024 | $0.08 | $0.00 | 0.00% | 42,000 | $0.08 | $0.08 | $0.08 |
12 Mar 2024 | $0.08 | $0.00 | 0.00% | 5,950 | $0.08 | $0.08 | $0.08 |
11 Mar 2024 | $0.08 | $0.00 | 0.00% | 6,350 | $0.08 | $0.08 | $0.08 |
08 Mar 2024 | $0.08 | $0.00 | 0.00% | 30,898 | $0.09 | $0.09 | $0.08 |
07 Mar 2024 | $0.09 | $0.00 | 0.00% | 29,002 | $0.08 | $0.09 | $0.08 |
06 Mar 2024 | $0.08 | $-0.01 | -10.75% | 31,340 | $0.08 | $0.08 | $0.08 |
05 Mar 2024 | $0.09 | $-0.01 | -10.20% | 88,724 | $0.10 | $0.10 | $0.09 |
04 Mar 2024 | $0.10 | $-0.01 | -9.52% | 24,204 | $0.11 | $0.11 | $0.10 |
01 Mar 2024 | $0.11 | $0.00 | 0.00% | 45,388 | $0.10 | $0.11 | $0.10 |
29 Feb 2024 | $0.10 | $0.00 | 0.00% | 136,327 | $0.10 | $0.10 | $0.10 |
28 Feb 2024 | $0.10 | $0.01 | 11.49% | 220,250 | $0.09 | $0.10 | $0.09 |
27 Feb 2024 | $0.09 | $0.01 | 12.35% | 118,848 | $0.08 | $0.09 | $0.08 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
21 Dec 2023 | Mark Bayliss | Issued | 166,667 | $30,000 |
Issue of securities.
|
21 Dec 2023 | Vanessa Wallace | Issued | 166,667 | $30,000 |
Issue of securities.
|
21 Dec 2023 | Bruce Robinson | Issued | 166,667 | $30,000 |
Issue of securities.
|
21 Dec 2023 | Michele Anderson | Issued | 166,667 | $30,000 |
Issue of securities.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Mark Richard Bayliss | Non-Executive Director | Sep 2022 |
Mr Bayliss has experience in a variety of roles across listed and private companies, management buyouts, private equity and turnarounds in Australia, NZ, UK and US. He has been the CEO of three listed companies and one private company and the Chairman of 3 companies and 2 not-for-profits. His industry experience includes eCommerce, Technology, Credit Finance, Retail, FMCG, Media & Publishing, Advertising & Marketing Services and Manufacturing. His other current directorships is with A2B Australia Limited. He is Chairman of the Risk and Compliance Committee (from 20 February 2023).
|
Ms Vanessa Miscamble Wallace | Interim MD & CEO | Nov 2023 |
Ms Wallace has a record as a director of listed and non-listed companies including Wesfarmers Ltd, SEEK Ltd, Doctor Care Anywhere PLC and Palladium Global Holdings Inc. Her executive career includes almost 30 years as a strategy management consultant, where she focused on financial services, health and consumer product industries, including co-leading the Booz & Company business in Japan for 4 years. Earlier in her career she was a Portfolio Manager with investment bank Schroders. Vanessa is an early-stage investor in the health sector and the founding Chairman of Australian digital health & biotechnology business, Drop Bio Pty Ltd. She is Member of the Risk and Compliance Committee and Health and Government Relations Committee. She is also Member of the People Committee. Her other current directorships are with Wesfarmers Ltd and SEEK Ltd and former directorships in last 3 years was held with Doctor Care Anywhere PLC.
|
Professor Bruce Gregory Robinson | Non-Executive Director | Mar 2021 |
Mr Robinson has over 25 years of experience as a board director, academic physician and scientist across research, healthcare and medicine, and tertiary education. He has experience covering academia, government, public and private health providers, research institutes and philanthropic organisations. Since 2015 Prof. Robinson has also chaired the Australian Government's National Health and Medical Research Council, and the Medical Benefits Schedule Review Task Force. He is Chairman of Health and Government Relations Committee and Member of the Risk and Compliance Committee (from 1 July 2023), Member of the People Committe. He is currently a director of QBiotics, a drug development
company. |
Ms Michele Anderson | Non-Executive Director | Mar 2022 |
Ms Anderson's career spans 30 years as an operating business executive, independent director and founder working across the technology, wine and professional services sectors. Her contributions and passion lie in developing and implementing growth strategy, scaling brands and businesses, driving digital growth and transformation, and supporting positive environmental impact and de-carbonisation. She began her career in Australia as a management consultant with Booz Allen and Hamilton and then spent most of her career to date working in the US, including running Shutterfly's US$1B revenue consumer ecommerce business in Silicon Valley and Staples' Print and Marketing Services business across 1,200 US stores. She is Chair of the People Committee, a Member of the Risk and Compliance Committee (from 1 July 2023) and Member of the People Committee.
|
Mr Jonathan Cedric Mengel Brown | Chief Financial OfficerCompany Secretary | Jan 2021 |
-
|
Ms Robin Sheldon | General CounselJoint Company Secretary | Jan 2021 |
-
|
Jonathan Cedric Mengel Brown | Chief Financial OfficerCompany Secretary |
-
|
|
Robin Sheldon | General CounselJoint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
HSBC Custody Nominees (Australia) Limited | 61,144,094 | 16.22% |
Barry Martin Lambert & Joy Wilma Lillian Lambert | 39,555,556 | 10.49% |
Barjoy Pty Ltd | 37,688,454 | 10.00% |
Phil Warner Pty Ltd | 32,306,381 | 8.57% |
Kylie Warner Pty Ltd | 16,340,072 | 4.33% |
Thomas Jefferson University | 12,178,259 | 3.23% |
Citicorp Nominees Pty Limited | 12,056,522 | 3.20% |
National Nominees Limited | 11,062,539 | 2.93% |
Eric Wang | 8,644,158 | 2.29% |
Pacific Custodians Pty Limited (Employee Securities TST Unallocated A/C) | 7,200,000 | 1.91% |
Warner Research Institute Limited | 6,648,700 | 1.76% |
Texsymmetry Inc | 6,595,959 | 1.75% |
Pacific Custodians Pty Limited (Employee Securities TST A/C | 6,269,786 | 1.66% |
Ubs Nominees Pty Ltd | 5,459,688 | 1.45% |
Jeffrey Bruner | 4,814,148 | 1.28% |
Freshwater Superannuation Fund Pty Limited | 4,017,830 | 1.07% |
Yarrawonga Holdings Pty Limited | 3,048,553 | 0.81% |
BT Portfolio Services Ltd | 2,929,730 | 0.78% |
Troncell Pty Ltd | 2,922,078 | 0.78% |
Eric Wang + Christie Wang <ATF The Ghengis Khan Super Fund> | 2,574,423 | 0.68% |